Other Clinical Trial - Assessing the Accuracy of the RevK Sensor

Clinical Trial Description

Evaluation of a new generation of sensors for monitoring blood hemoglobin with the Masimo non-invasive hemoglobin monitor. The newest sensor version is RevK. ;

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Patients Undergoing Spine Surgery

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03644407` - Galeazzi Spine Surgery RegistryGaleazzi Spine Registry: Prospective Study for Clinical Monitoring
Completed	`NCT01750554` - The Influence of a Bupivacaine Digital Nerve Block Using Rev G.	N/A
Completed	`NCT04994704` - Comparison of Postoperative QoR-15 Scores Between Propofol and Remimazolam	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT03644407 - Galeazzi Spine Surgery RegistryGaleazzi Spine Registry: Prospective Study for Clinical Monitoring

Completed

NCT01750554 - The Influence of a Bupivacaine Digital Nerve Block Using Rev G.

N/A

Completed

NCT04994704 - Comparison of Postoperative QoR-15 Scores Between Propofol and Remimazolam

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01877876
Study type	Observational
Source	University of California, San Francisco
Contact
Status	Completed
Phase	N/A
Start date	June 2013
Completion date	June 2015

Assessing the Accuracy of the RevK Sensor

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms